Hybrid AF™ Therapies Summit – December 1, 2023

1 December, 2023 - Hamburg, Germany

The 6th edition of the Hybrid AF™ Therapies Summit is going to take place at the Asklepios Klinikum, in Hamburg-Harburg, Germany. Join your colleagues on December 1 for a program covering AF treatment with Hybrid AF™ Therapies.

The program will explore how Hybrid AF™ Therapies are shaping new standards of care in atrial fibrillation advanced treatment.
Led by an international panel of speakers, the event will include sessions and roundtables on latest clinical trial results, best practices, patient selection criteria and procedural considerations.

The “Save the Date” flyer is available for download.

You can also download the booklet for the summit here

Audience
Electrophysiologists and Cardiac Surgeons who are interested in developing a Hybrid AF program, or have already started it and would like to further advance their expertise through discussions with peers.

Level
All levels

Faculty
International Faculty

Agenda

The program commences on Friday, December 1, from 08:30 until 17:00 CET

Topics include:

– Progresses and challenges of persistent and long-standing persistent AF management
– Rationale and principles of epicardial/endocardial ablation
– Latest clinical evidence
– Procedural aspects of Convergent and Total Thoracoscopic Ablation therapies
– Ask the expert sessions
– Live in a box cases

Venue
Asklepios Klinikum Harburg
Eißendorfer Pferdeweg 52
21075 Hamburg
Germany

Accommodation
Hotel bookings will be allocated on an individual basis and you will receive a reservation confirmation by email. Please check your travel details tab in your AF Connect dashboard for your details.

 

Agenda
Day 1
Morning

8:30 am - 8:45 am

Welcome Message — Geoff Stevens, Thorsten Hanke, MD

8:45 am - 10:45 am

Epicardial/Endocardial Strategies for Advanced AF Treatment — Thorsten Hanke, Konstantin Krieger

  • Progress and Challenges in Advanced AF Treatment — Claudio Tondo, MD

  • The Complexity of Activation Patterns in Persistent Forms of AF — Randall Lee, MD

  • What Recent Studies Tell Us About LAPWI — Riyaz Kaba, MD

  • The Role of Hybrid Ablation at the Times of PFA Revolution — Nitesh Sood, MD

  • Hybrid Ablation Evidence — Nicolas Doll, MD

  • Panel Discussion

10:45 am - 11:15 am

Coffee Break

11:15 am - 11:35 am

Why the LAA Should Be Incorporated During a Hybrid Procedure: The Role of LAA in AF — Syed Ahsan, MD

11:35 am - 1:00 pm

The Hybrid AF™ Convergent Therapy — Jaswinder Gill, MD, Konstantinos Zannis, MD

  • From the Surgeon Point of View: Technique and Lesion Set — Thomas Barker, MD

  • From the EP Point of View: Managing Patients After an Epicardial Ablation — Faizel Osman, MD

  • Case-based Presentations

    • What I Understood by Mapping in the OR — Nitesh Sood, MD

    • Why I Treat De Novo Patients — Eduardo Celentano, MD

    • How to Reduce Peri-Operative Complications Risk — Christoph Thomas Starck, MD

  • Panel Discussion
Afternoon

1:00 pm - 2:00 pm

Lunch

2:00 pm - 2:30 pm

Physicians-Patients Interactions in the Age of Social Media — Edin Smailhodzic

2:30 pm - 4:00 pm

The Hybrid Total Thoracoscopic Ablation Therapy — Manuela Cireddu, MD, Elisabetta Lapenna, MD

  • From the Surgeon Point of View: Technique and Lesion Set — Bart van Putte, MD

  • From the EP Point of View: Managing Patients After an Epicardial Ablation — David Filgueiras Rama, MD

  • Case-based Presentations

    • Why Considering the All-Box-Clamp Technique — Timo Weimar, MD

    • Why Thinking About Single-Stage, Unilateral Approach — Mark La Meir, MD

    • How to Face the Challenges of High BMI Patients — Manuel Carnero Alcázar, MD

  • Panel Discussion

4:00 pm - 4:30 pm

Hybrid Sinus Node Sparing: Principles and Perspectives — Carlo de Asmundis, MD

4:30 pm - 4:30 pm

Closing & Departures — Carlo de Asmundis, MD